Go to Page # Page of 20

Approaches to overcome CAR-T cell toxicity: anticytokine antibodies and suicide genes

 Christian Chabannion
  11th-Dec-2017
Description: Partnership between cell processing facilities and hospital pharmacies for the delivery and administration of CAR-T Cells.
Views: 798
Domain: Medical
Category: Biotech/Pharma
Contributing Organization: MolMed S.p.A.
 ‐ More of their Presentations
Contents:
CAR-T Cells enter center stage !
COSTEM, Berlin, October 2017
Molmed sponsored symposium
»Approaches to potentially overcome CAR-T
cell toxicity: anticytokine antibodies and
suicide genes"
Christian CHABANNION
Aix_Marseille Université School of Medicine
Institut Paoli-Calmettes, Marseille
& Centre d’Investigations Cliniques en Biothérapies de
Marseille, Inserm CBT-1409

... See more

Recent Presentations

Trends in Neuro Device Investing

Healthy step-ups are common for early and mid-series rounds; however as with medical devices in general, step-ups become far more difficult at later-series rounds in the absence of

...
20 April, 2018
...
19 April, 2018
...
18 April, 2018